Your browser doesn't support javascript.
loading
Morphological Response in Cancer Spheroids for Screening Photodynamic Therapy Parameters.
Aguilar Cosme, Jose R; Gagui, Dan C; Bryant, Helen E; Claeyssens, Frederik.
Afiliação
  • Aguilar Cosme JR; Department of Materials Science and Engineering, Kroto Research Institute, University of Sheffield, Sheffield, United Kingdom.
  • Gagui DC; INSIGNEO Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom.
  • Bryant HE; INSIGNEO Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom.
  • Claeyssens F; Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, United Kingdom.
Front Mol Biosci ; 8: 784962, 2021.
Article em En | MEDLINE | ID: mdl-34869604
ABSTRACT
Photodynamic therapy (PDT) is a treatment which uses light-activated compounds to produce reactive oxygen species, leading to membrane damage and cell death. Multicellular cancer spheroids are a preferable alternative for PDT evaluation in comparison to monolayer cell cultures due to their ability to better mimic in vivo avascular tumour characteristics such as hypoxia and cell-cell interactions, low cost, and ease of production. However, inconsistent growth kinetics and drug responsiveness causes poor experimental reproducibility and limits their usefulness. Herein, we used image analysis to establish a link between human melanoma C8161 spheroid morphology and drug responsiveness. Spheroids were pre-selected based on sphericity, area, and diameter, reducing variation in experimental groups before treatment. Spheroid morphology after PDT was analyzed using AnaSP and ReViSP, MATLAB-based open-source software, obtaining nine different parameters. Spheroids displayed a linear response between biological assays and morphology, with area (R2 = 0.7219) and volume (R2 = 0.6138) showing the best fit. Sphericity, convexity, and solidity were confirmed as poor standalone indicators of spheroid viability. Our results indicate spheroid morphometric parameters can be used to accurately screen inefficient treatment combinations of novel compounds.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article